Digital Marketing Trends in Colorectal Cancer
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Digital Marketing Trends in Colorectal Cancer Report Overview
Merck’s Keytruda.com achieved the highest total traffic across colorectal cancer (CRC) patient sites in the US. This was followed by Bristol Myers Squibb’s (BMS’s) Opdivo.com and Roche’s Avastin.com. Overall, the highest proportion of traffic to top branded patient CRC websites originated from direct sources, followed by organic sources.
The Digital Marketing Trends in the Colorectal Cancer research report assesses key digital marketing metrics of pharma assets in CRC, including branded websites for patients and healthcare professionals (HCPs), mobile apps, and social media accounts. The report offers metrics on website traffic volume, engagement, source, digital display advertising (DDA), paid search engine optimization (SEO), and social media post interaction.
Key US Patient-Branded Websites | · Keytruda.com
· Opdivo.com · Avastin.com · Stivarga-us.com · Lonsurf.com · Cyramza.com |
Key US HCP Branded Websites | · Keytrudahcp.com
· Opdivohcp.com · Rozlytrek-hcp.com · Lonsurfhcp.com · Hcp.stivarga-us.com |
Key EUCAN Unbranded Websites | · Daskwort.de
· Lavieautour.fr |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Major US Patient Branded Websites for Colorectal Cancer
The major US patient-branded websites for Colorectal Cancer are Keytruda.com, Opdivo.com, Avastin.com, Stivarga-us.com, Lonsurf.com, and Cyramza.com. Merck’s Keytruda.com achieved the highest total traffic across CRC patient sites in the US from August 2022 to July 2023, followed by BMS’s Opdivo.com and Roche’s Avastin.com.
Traffic Share to Branded US CRC Patient Sites, August 2022–July 2023 (%)
Buy the Full Report for More into Total Traffic Share Insights of the US Patient-Branded Websites Download A Free Report Sample
Major US HCP Branded Websites for Colorectal Cancer
The major US HCP-branded websites for Colorectal Cancer are Keytrudahcp.com, Opdivohcp.com, Rozlytrek-hcp.com, Lonsurfhcp.com, and Hcp.stivarga-us.com. Merck’s Keytrudahcp.com achieved the highest total traffic across CRC patient sites in the US from August 2022 to July 2023, followed by BMS’s Opdivohcp.com. Furthermore, Rozlytrek-hcp.com achieved the highest average visit duration and Hcp.stivarga-us.com had the highest pages per visit.
Traffic Share to Branded US CRC HCP Sites, August 2022–July 2023 (%)
Buy the Full Report for More Insights into The Total Traffic Share of The US HCP Branded Websites Download A Free Report Sample
Top US Social Media Activity in Colorectal Cancer
From August 2022 to July 2023, 17 CRC-related social media posts were detected from pharma companies, including Pfizer, Roche, Loxo Lilly, Taiho Oncology, and Genentech. The post with the most interaction was from Loxo Lilly Oncology’s account on X on CRC awareness month, highlighting the importance of regular screening.
Major EUCAN Unbranded Websites for Colorectal Cancer
From August 2022 to July 2023, Roche’s Daskwort.de had a total traffic of more than 300,000 visits, while Pfizer’s Lavieautour.fr had a total traffic of more than 26,000 visits. Pfizer’s Lavieautour.fr had the highest percentage of traffic from direct searches, while Roche’s Daskwort.de had the highest percentage of organic searches. Moreover, traffic from referrals and social searches was minimal.
Buy the Full Report for More Insights into The Total Traffic Share of the EUCAN-Unbranded Websites Download A Free Report Sample
Top EUCAN Social Media Activity in Colorectal Cancer
From August 2022 to July 2023, 98 social media posts related to CRC were detected from pharma companies, including Bayer, Amgen, Pfizer, MSD, and BMS. The post with the most interaction was from Bayer’s Facebook account, highlighting the importance of screening for CRC.
Scope
This report assesses key digital marketing metrics of pharma assets in PsO, including branded websites for patients and HCPs, Unbranded websites, and social media accounts.
• Metrics include website traffic volume, engagement, and source, DDA, paid SEO, and social media post interaction.
• Countries include the US, 4EU (Italy, France, Germany, and Spain), the UK, and Canada (EUCAN).
Key Highlights
CRC, Colorectal Cancer, digital marketing, website traffic, search engine optimization, SEO, digital display advertising, social media
Reasons to Buy
- Understand the digital marketing competitive landscape in CRC with a view of leading patient and HCP branded assets across different regions.
- See what tactics pharma companies are using to drive traffic to their CRC-branded assets for patients and HCPs, such as DDA and paid SEO.
- Understand what sources of website traffic are generating the most visits to these assets, such as paid SEO, social media, or organic searches.
- Compare top branded and unbranded assets for patients by how they address and support different patient needs.
- See what pharma social media accounts in CRC are the most active and achieving the most engagement.
Roche
Eli Lilly
Bayer
Pfizer
BMS
Table of Contents
Frequently asked questions
-
Which is the leading US patient-branded website for Colorectal Cancer?
Keytruda.com is the leading US patient-branded website for Colorectal Cancer.
-
Which is the leading US HCP-branded website for Colorectal Cancer?
Keytrudahcp.com is the leading US HCP-branded website for Colorectal Cancer.
-
Which US social media account for Colorectal Cancer had the highest engagement from August 2022 to July 2023?
Loxo Lilly Oncology’s post on X on CRC awareness month had the most interaction from August 2022 to July 2023.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.